[{"Assets_0_Q1_USD":32937000000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.39,"EarningsPerShareBasic_1_Q1_USD":0.95,"EarningsPerShareDiluted_1_Q1_USD":0.94,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":861000000.0,"NetIncomeLoss_1_Q1_USD":1574000000.0,"StockholdersEquity_0_Q1_USD":14416000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1671000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1662000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170427"}]